Cagrilintide vs Semaglutide: Which Wins for Weight?
Semaglutide is the stronger standalone choice today; cagrilintide is still experimental and mainly studied as an add-on to semaglutide, not a replacement for it.
Quick Answer
Semaglutide is for people who want a proven, FDA-approved weight-loss drug with years of real-world data. Cagrilintide is for people following its trial results, as it has no approved standalone use yet. The verdict: semaglutide wins as a solo drug; cagrilintide's best data comes from being combined with semaglutide .
What Is Semaglutide?
Semaglutide (brand names Ozempic for diabetes and Wegovy for weight loss) is a weekly injection. It copies a gut hormone called glucagon-like peptide 1 (GLP-1).
GLP-1 tells your body to release insulin. It also slows stomach emptying and reduces hunger signals in the brain. Semaglutide is FDA-approved and has several years of post-market safety data .
Typical doses for weight loss range from 0.25 mg to 2.4 mg per week, depending on how your body tolerates it (source).
What Is Cagrilintide?
Cagrilintide is a long-acting copy of amylin, a hormone your pancreas releases right after you eat.
Natural amylin slows stomach emptying and acts on the brain to signal fullness. Cagrilintide mimics this signal but stays active in the body much longer than natural amylin does .
As of 2026, cagrilintide has no standalone FDA approval. It is still in late-stage clinical trials . Doses used in trials ranged from 0.16 mg to 4.5 mg per week (source).
How Do Semaglutide and Cagrilintide Work Differently?
These two drugs work through completely separate systems in your body.
Semaglutide acts on the GLP-1 receptor. Cagrilintide acts on amylin receptors.
Because they target different pathways, they do not compete with each other. This is exactly why researchers are studying them together.
Mechanism: Semaglutide copies a gut hormone (GLP-1). Cagrilintide copies a pancreas hormone (amylin).
Primary use: Semaglutide is approved for type 2 diabetes and obesity. Cagrilintide has no approved standalone indication.
Typical research dose:
- Semaglutide: 0.25 mg to 2.4 mg per week (source)
- Cagrilintide: 0.16 mg to 4.5 mg per week in trials (source)
Onset: Semaglutide typically reduces appetite within the first few weeks . Standalone onset data for cagrilintide is limited because most research pairs it with semaglutide.
Evidence level: Semaglutide has large, completed Phase 3 trials and FDA approval . Cagrilintide's standalone human data is thin. The strongest evidence for cagrilintide comes from the CagriSema combination study (source), not from using it alone.
For people running a protocol with either of these compounds, DoseVault is a straightforward way to log weekly doses and track how your weight and appetite shift over time.
How Do Semaglutide and Cagrilintide Compare Side by Side?
| Feature | Semaglutide | Cagrilintide |
|---|---|---|
| Receptor target | GLP-1 receptor | Amylin receptors |
| Injection frequency | Once a week | Once a week (in trials) |
| Typical trial dose | 0.25 to 2.4 mg/week | 0.16 to 4.5 mg/week |
| FDA approval status | Approved (obesity and diabetes) | Not approved standalone |
| Standalone human evidence | Strong Phase 3 data | Limited |
| Main evidence source | Solo trials (STEP series) | CagriSema combination trial |
Can You Use Both Together?
Yes, and this is actually the main reason cagrilintide is in the news.
The CagriSema combination study tested semaglutide 2.4 mg plus cagrilintide 2.4 mg given together each week. Early results showed larger weight loss than either drug alone . This makes sense because they act on different receptors and do not overlap.
This combination is not yet approved as of 2026 (source). Do not combine drugs outside of a supervised clinical setting.
Which One Do People Pick, and When?
Right now, almost no one is choosing between these two as alternatives. That is because cagrilintide has no standalone approval.
Most people who are interested in cagrilintide are watching the CagriSema trial results. They are waiting to see whether the combination gets approved. Anyone looking for a weight-loss drug today will be pointed to semaglutide or another approved option, not cagrilintide on its own.
This is general guidance, not personalized medical advice. Speak with a licensed clinician before starting any drug.
Related
- Cagrilintide
- Semaglutide
- AOD-9604 vs Semaglutide
- Are Research Peptides the Same as Prescription Peptides?
- Berberine vs Semaglutide
- How to Reconstitute Semaglutide
- Peptides for Fat Loss
Disclaimer
This page is for educational purposes only. It is not medical advice. Nothing here should be used to diagnose, treat, cure, or prevent any condition. Consult a qualified healthcare provider before starting any medication or protocol.
Built by medical professionals, gym rats, and experienced biohackers
If you are tracking a semaglutide protocol and want to monitor your weekly dose and progress, DoseVault makes it simple to log your schedule and body response over time.